The World Health Organization (WHO), GAVI, the Vaccine Alliance, and UNICEF jointly announce today the existing Malaria Vaccine Implementation Program will expand over the next two years to reach twelve African countries.
In addition to Ghana, Kenya, and Malawi, the initial 18 million malaria vaccine allocation will enable nine more countries, including Benin, Burkina Faso, Burundi, Cameroon, the Democratic Republic of the Congo, Liberia, Niger, Sierra Leone, and Uganda, to introduce the vaccine into their routine immunization programs for the first time.
Malaria Vaccinations Expand Across Africa
Third RSV Vaccine Seeks Various Approvals
As the 2023 Respiratory Syncytial Virus (RSV) season approaches the United States, a third vaccine may soon become available for older adults.
Moderna, Inc. today provided an update on regulatory submissions for mRNA-1345, a vaccine candidate for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.
COVID-19 Vaccines Have a Good Safety Profile
An expansive group of international medicine regulatory authorities confirmed vaccines aimed at protecting people from severe outcomes of COVID-19 have a very good safety profile in all age groups.
European Medicines Agency (EMA) today announced it endorsed a joint statement on the safety of COVID-19 vaccines issued by the International Coalition of Medicines Regulatory Authorities (ICMRA).
CDC: More Than Three-Quarters of Americans 16 and Older Have Been Infected With COVID-19
Federal figures have made it clear how much the virus spread undetected or unreported